Cardiff Lexington Corp
Close on Oct 19, 2026
- Market cap
- $534.29K
- P/E (TTM)
- –
- Dividend yield
- –
About Cardiff Lexington
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
Cardiff Lexington Corporation operates as a healthcare holding company focused on acquiring and developing middle-market niche healthcare practices, primarily targeting orthopedics, spine care, and pain management. The company generates all of its operating revenue through its subsidiary, Nova Ortho and Spine, LLC, which provides traumatic injury victims with primary care evaluations, interventional pain management, emergency medical condition assessments, and diagnostic and surgical services. Its medical services cater primarily to uninsured patients and individuals involved in personal injury litigation following accidents. Additionally, the company owns Edge View Properties, Inc., a real estate subsidiary holding undeveloped residential and agricultural land.
The company operates regional primary specialty and ancillary care facilities across Florida and Georgia. Edge View Properties holds twenty-three acres of land situated in Lemhi County, Idaho, near the City of Salmon. Cardiff Lexington Corporation maintains its principal executive offices in Lexington, Kentucky.
Summary of the business section of Cardiff Lexington's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Cardiff Lexington Corp
- Founded
- 1986
- Headquarters
- Lexington, KY
- Address
- 710 East Main Street 40502
- Phone
- (844) 628-2100
- Employees
- 18, Dec 31, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Incorporated in
- Florida
- Fiscal year ends
- December 31
- Auditor
- GBQ Partners, LLC, Columbus, Ohio
Stock & identifiers
- Ticker
- CDIX
- Exchange
- OTC
- Shares outstanding
- 16M, Aug 10, 2026
- Public float
- $45.40M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-3 reverse, Mar 10, 2026; 1-for-3 reverse, Jan 12, 2026; 1-for-74997 reverse, Mar 27, 2024; 1-for-75000 reverse, Jan 9, 2024; 1-for-9999 reverse, Aug 14, 2020; 1-for-10000 reverse, May 12, 2020; 1-for-1500 reverse, Apr 22, 2019; 1-for-1500 reverse, Mar 25, 2019; 1-for-25000 reverse, Nov 25, 2014; 1-for-25000 reverse, Sep 12, 2014
- SEC CIK
- 811222
- EIN
- 84-1044583
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Alex H. Cunningham | Chief Executive Officer, Director | 4,803,628 |
| Daniel Thompson | Chairman of the Board, Director | 11,702,557 |
| Matthew T. Shafer | Chief Financial Officer | 74,168 |
| Catherine B. Pennington | Director | 11,668 |
| Louis Jack Staley Sr. | Director | 11,668 |
| Gillard B. Johnson III | Director | 11,668 |
Employees
Headcount reported in annual reports
“As of December 31, 2025, our company had 18 employees,”
Corporate history
Events identified from SEC filings